The role of thermogenesis in antipsychotic drug-induced weight gain

Obesity

Volumn 17, Issue 1, 2009, Pages 16-24

  Stefanidis, Aneta ^a   Verty, Aaron N A ^a   Allen, Andrew M ^b   Owens, Neil C ^a   Cowley, Michael A ^c   Oldfield, Brian J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Orexigen Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL; ANTERIOR HYPOTHALAMUS; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; DRUG EFFECT; FEMALE; HYPOTHALAMUS; MEDULLA OBLONGATA; MOTOR ACTIVITY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; THERMOGENESIS; WEIGHT GAIN;

ADIPOSE TISSUE, BROWN; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY WEIGHT; ENERGY INTAKE; FEMALE; HYPOTHALAMUS; MEDULLA OBLONGATA; MOTOR ACTIVITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; THERMOGENESIS; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 57949084753     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.468     Document Type: Article

References (57)

1. Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 2001;62(Suppl 7):22-31.
2. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003;28(Suppl 1):83-96.
3. Fontaine KR, Heo M, Harrigan EP et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res 2001;101:277-288.
4. Umbricht DS, Pollack S, Kane JM. Clozapine and weight gain. J Clin Psychiatry 1994;55(Suppl B):157-160.
5. Masand PS. Weight gain associated with psychotropic drugs. Expert Opin Pharmacother 2000;1:377-389.
6. Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696.
7. Arjona AA, Zhang SX, Adamson B, Wurtman RJ. An animal model of antipsychotic-induced weight gain. Behav Brain Res 2004;152:121-127.
8. Cope MB, Nagy TR, Fernandez JR et al. Antipsychotic drug-induced weight gain: development of an animal model. Int J Obes (Lond) 2005;29:607-614.
9. Goudie AJ, Smith JA, Halford JC. Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 2002;16:291-296.
10. Pouzet B, Mow T, Kreilgaard M, Velschow S. Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 2003;75:133-140.
11. Cooper GD, Pickavance LC, Wilding JP, Halford JC, Goudie AJ. A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 2005;181:80-89.
12. Gothelf D, Falk B, Singer P et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002;159:1055-1057.
13. Eder U, Mangweth B, Ebenbichler C et al. Association of olanzapineinduced weight gain with an increase in body fat. Am J Psychiatry 2001;158:1719-1722.
14. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic: Sydney, Australia,1998.
15. Sharpe JK, Byrne NM, Stedman TJ, Hills AP. Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication. J Am Diet Assoc 2005;105:612-615.
16. Sharpe JK, Stedman TJ, Byrne NM, Wishart C, Hills AP. Energy expenditure and physical activity in clozapine use: implications for weight management. Aust N Z J Psychiatry 2006;40:810-814.
17. Virkkunen M, Wahlbeck K, Rissanen A, Naukkarinen H, Franssila-Kallunki A. Decrease of energy expenditure causes weight increase in olanzapine treatment-a case study. Pharmacopsychiatry 2002;35:124-126.
18. Cunningham S, Leslie P, Hopwood D et al. The characterization and energetic potential of brown adipose tissue in man. Clin Sci (Lond) 1985;69:343-348.
19. Jung RT, Leslie P, Nicholls DG, Cunningham S, Isles TE. Energy expenditure in normal and diabetic man: the role of brown adipose tissue. Health Bull (Edinb) 1988;46:55-62.
20. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000;404:652-660.
21. Heaton JM. The distribution of brown adipose tissue in the human. J Anat 1972;112:35-39.
22. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007;293:E444-E452.
23. Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue uncoupling protein content in human infants, children and adults. Clin Sci (Lond) 1986;71:291-297.
24. Garruti G, Ricquier D. Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans. Int J Obes Relat Metab Disord 1992;16:383-390.
25. Kortelainen ML, Pelletier G, Ricquier D, Bukowiecki LJ. Immunohistochemical detection of human brown adipose tissue uncoupling protein in an autopsy series. J Histochem Cytochem 1993;41:759-764.
26. Cinti S. The role of brown adipose tissue in human obesity. Nutr Metab Cardiovasc Dis 2006;16:569-574.
27. Lean ME, Trayhurn PJM. Brown adipose tissue in humans. J Obes Weight Regul 1987;6:234-253.
28. Oberkofler H, Beer A, Breban D et al. Human obese gene expression: alternative splicing of mRNA and relation to adipose tissue localization. Obes Surg 1997;7:390-396.
29. Krief S, Lonnqvist F, Raimbault S et al. Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 1993;91:344-349.
30. Bouillaud F, Villarroya F, Hentz E et al. Detection of brown adipose tissue uncoupling protein mRNA in adult patients by a human genomic probe. Clin Sci (Lond) 1988;75:21-27.
31. Huttunen P, Hirvonen J, Kinnula V. The occurrence of brown adipose tissue in outdoor workers. Eur J Appl Physiol Occup Physiol 1981;46:339-345.
32. Walston J, Silver K, Bogardus C et al. Time of onset of non-insulindependent diabetes mellitus and genetic variation in the β3-adrenergicreceptor gene. N Engl J Med 1995;333:343-347.
33. Clement K, Vaisse C, Manning BS et al. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-354.
34. Widen E, Lehto M, Kanninen T et al. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
35. Fumeron F, Durack-Bown I, Betoulle D et al. Polymorphisms of uncoupling protein (UCP) and β3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord 1996;20:1051-1054.
36. Nagai N, Sakane N, Ueno LM, Hamada T, Moritani T. The -3826 AG variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. J Clin Endocrinol Metab 2003;88:5661-5667.
37. Enerback S, Jacobsson A, Simpson EM et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997;387: 90-94.
38. Liu X, Rossmeisl M, McClaine J et al. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest 2003;111:399-407.
39. Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW. Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl) 1996;124:87-94.
40. Bymaster FP, Nelson DL, DeLapp NW et al. Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro. Schizophr Res 1999;37:107-122.
41. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 2000;68: 29-39.
42. Casey DE, Zorn SH. The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 2001;62(Suppl 7):4-10.43.
43. Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH. From the Cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci USA 2007;104:3456-3459.
44. Bamshad M, Song CK, Bartness TJ. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 1999;276:R1569- R1578.
45. Oldfield BJ, Giles ME, Watson A et al. The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 2002;110:515-526.
46. Cano G, Passerin AM, Schiltz JC et al. Anatomical substrates for the central control of sympathetic outflow to interscapular adipose tissue during cold exposure. J Comp Neurol 2003;460:303-326.
47. Fadel J, Bubser M, Deutch AY. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 2002;22:6742-6746.
48. Oldfield BJ, Allen AM, Davern P, Giles ME, Owens NC. Lateral hypothalamic "command neurons" with axonal projections to regions involved in feeding and thermogenesis. Eur J Neurosci 2007;25:2404-2412.
49. Cerri M, Morrison SF. Activation of lateral hypothalamic neurons stimulates brown adipose tissue thermogenesis. Neuroscience 2005;135:627-638.
50. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999;22:221-232.
51. Allen GV, Cechetto DF. Functional and anatomical organization of cardiovascular pressor and depressor sites in the lateral hypothalamic area: I. Descending projections. J Comp Neurol 1992;315:313-332.
52. Haynes AC, Chapman H, Taylor C et al. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul Pept 2002;104:153-159.
53. Wang J, Osaka T, Inoue S. Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats. Neurosci Lett 2001;315:49-52.
54. Monda M, Viggiano A, Mondola P, De Luca V. Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A. Brain Res 2001;909:68-74.
55. Antunes VR, Brailoiu GC, Kwok EH, Scruggs P, Dun NJ. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am J Physiol Regul Integr Comp Physiol 2001;281:R1801-R1807.
56. van den Top M, Nolan MF, Lee K et al. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol 2003;549:809-821.
57. Tanida M, Niijima A, Shen J et al. Dose-different effects of orexin-A on the renal sympathetic nerve and blood pressure in urethane-anesthetized rats. Exp Biol Med (Maywood) 2006;231:1616-1625.